Diagnostics News and Research RSS Feed - Diagnostics News and Research

Columbia University Medical Center to evaluate Biocept's Target Selector platform to diagnose LM in breast cancer patients

Columbia University Medical Center to evaluate Biocept's Target Selector platform to diagnose LM in breast cancer patients

Biocept, Inc., a leading commercial provider of clinically actionable liquid biopsy tests designed to improve the outcomes of cancer patients, announces that Columbia University Medical Center will conduct a study to evaluate the clinical utility of the Company's Target Selector™ platform to diagnose leptomeningeal metastases (LM) in patients with breast cancer. [More]
Mutations linked to endometrial cancer can be found in uterine lavage fluid before cancer diagnosis

Mutations linked to endometrial cancer can be found in uterine lavage fluid before cancer diagnosis

Mutations that have been linked to endometrial cancer can be found in the uterine lavage fluid of pre- and post-menopausal women both with and without detectable cancer, according to a study published in PLOS Medicine by John Martignetti, MD, PhD of the Icahn School of Medicine at Mount Sinai and colleagues. [More]
Nexmos, Base Pair Biotechnologies create new class of DNA-aptamer based oxidation inhibitors

Nexmos, Base Pair Biotechnologies create new class of DNA-aptamer based oxidation inhibitors

Base Pair Biotechnologies, Inc., The Aptamer Discovery Company, and Nexmos, Inc., the Aptamer Application R&D Company, announce the creation of a new class of DNA-aptamer based oxidation inhibitors. [More]
Alere provides update on CMS decision to revoke Medicare billing privileges of Arriva Medical

Alere provides update on CMS decision to revoke Medicare billing privileges of Arriva Medical

Alere Inc., a global leader in rapid diagnostic tests, today provided an update on the decision by the Centers for Medicare & Medicaid Services (CMS) to revoke Arriva Medical's Medicare billing privileges. [More]
New study shows efficacy of Ebola vaccine in offering protection against disease

New study shows efficacy of Ebola vaccine in offering protection against disease

An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to a new study that included researchers from the University of Maryland School of Medicine. [More]
Experimental Ebola vaccine offers high protection against deadly virus, reveals major trial

Experimental Ebola vaccine offers high protection against deadly virus, reveals major trial

An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to results published today in The Lancet. The vaccine is the first to prevent infection from one of the most lethal known pathogens, and the findings add weight to early trial results published last year. [More]
Scientists discover OGDHL and NRD1 genes linked to progressive loss of neurological function

Scientists discover OGDHL and NRD1 genes linked to progressive loss of neurological function

An international team of scientists has discovered that the gene, OGDHL, a key protein required for normal function of the mitochondria -- the energy-producing factory of the cell -- and its chaperone, nardilysin (NRD1) are linked to progressive loss of neurological function in humans. [More]
OIST researchers create novel sensor that detects biomolecules

OIST researchers create novel sensor that detects biomolecules

OIST researchers create a novel sensor capable of measuring both charge and mass of biomolecules with potential applications in healthcare diagnostics. [More]
Agendia data reveals impact of MammaPrint on adjuvant treatment decisions in breast cancer patients

Agendia data reveals impact of MammaPrint on adjuvant treatment decisions in breast cancer patients

Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, has presented new prospective data demonstrating the strong impact of its 70-Gene Breast Cancer Recurrence assay, MammaPrint, and the corresponding 80-Gene Molecular Subtyping Assay BluePrint, in clinical decision-making for patients with early-stage breast cancer in Germany. [More]
Clinical Genomics introduces new blood-based test for CRC recurrence monitoring

Clinical Genomics introduces new blood-based test for CRC recurrence monitoring

Clinical Genomics, a private company developing evidence-based diagnostic tools for colorectal cancer, today announced the launch of Colvera, a blood-based test for colorectal cancer (CRC) recurrence monitoring. Colvera is the result of a decade of research, development and clinical validation in more than 4,000 patients. [More]
FDA expands approved use of G5 Mobile Continuous Glucose Monitoring System

FDA expands approved use of G5 Mobile Continuous Glucose Monitoring System

The U.S. Food and Drug Administration today expanded the approved use of Dexcom's G5 Mobile Continuous Glucose Monitoring System to allow for replacement of fingerstick blood glucose (sugar) testing for diabetes treatment decisions in people 2 years of age and older with diabetes. [More]
Wellcome Trust Sanger Institute establishes spin-out company, Microbiotica

Wellcome Trust Sanger Institute establishes spin-out company, Microbiotica

Cambridge Innovation Capital plc, a Cambridge-based investor in technology and healthcare companies, and IP Group plc, the developer of intellectual property-based businesses, announce the creation of Microbiotica Ltd, a newly formed spin-out company from the UK’s Wellcome Trust Sanger Institute based at the Wellcome Genome Campus in Hinxton, Cambridge. [More]
Hormone receptor could be potential biomarker for gastric cancer, research shows

Hormone receptor could be potential biomarker for gastric cancer, research shows

Scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, the Veterans Affairs Medical Center in Miami, and Shantou University Medical College in China, have shown that the hormone receptor GHRH-R could be a potential biomarker for gastric cancer, enabling earlier diagnoses and better staging. [More]
How can we tackle antimicrobial resistance?

How can we tackle antimicrobial resistance?

Antimicrobial resistance happens when bugs, like bacteria, fungi or viruses, change, or evolve, when they’re exposed to drugs, like antibiotics, antifungals, or antivirals. Bugs that develop antimicrobial resistance are sometimes referred to as ‘superbugs’. [More]
AMP publishes joint guidelines for interpretation, reporting of sequence variants in cancer

AMP publishes joint guidelines for interpretation, reporting of sequence variants in cancer

The Association for Molecular Pathology (AMP), the premier global, non-profit molecular diagnostics professional society, today published guideline recommendations for both clinical laboratory professionals and oncologists that assess the status of next-generation sequencing (NGS)-based cancer tests and establish standardized classification, annotation, interpretation, and reporting conventions for somatic sequence variants. [More]
Sphere Medical launches next generation Proxima for bedside blood gas and glucose analysis

Sphere Medical launches next generation Proxima for bedside blood gas and glucose analysis

Sphere Medical, an innovative company in critical care monitoring and diagnostics equipment, has launched its next generation CE-marked Proxima system. [More]
Portable detection system can rapidly identify virulent, multi-drug resistant pathogens in remote areas

Portable detection system can rapidly identify virulent, multi-drug resistant pathogens in remote areas

A team of researchers has developed a portable detection system that can rapidly identify some of the most virulent, often multi-drug resistant pathogens. [More]
Excelitas launches new X-Cite Vitae vIR system for endoscopy and surgical visualization applications

Excelitas launches new X-Cite Vitae vIR system for endoscopy and surgical visualization applications

Excelitas Technologies Corp., a global technology leader focused on delivering innovative, customized photonic solutions, adds X-Cite VitaeTM vIR to its popular X-Cite fluorescence illuminator product line. X-Cite Vitae vIR is a customizable, multi-wavelength illumination system designed for high precision medical illumination and diagnostic applications. [More]
Micronic Univo Screw Cap Recapper could effectively seal valuable DNA samples

Micronic Univo Screw Cap Recapper could effectively seal valuable DNA samples

RadboudUMC, one of the largest and leading Academic Medical Centers in The Netherlands, has reported on its effective use of the Micronic Univo Screw Cap Recapper SR096 to securely seal its valuable DNA samples. [More]
Pacific Edge announces commercial launch of Cxbladder Monitor in the U.S.

Pacific Edge announces commercial launch of Cxbladder Monitor in the U.S.

Pacific Edge Limited, a cancer diagnostics company developing and commercializing a suite of non-invasive tests for the detection and management of bladder cancer, announces today the commercial launch of the third product in the Company's Cxbladder family of products, Cxbladder Monitor, in the United States. [More]
Advertisement
Advertisement